PENMENIVY Trademark

Trademark Overview


On Wednesday, February 2, 2022, a trademark application was filed for PENMENIVY with the United States Patent and Trademark Office. The USPTO has given the PENMENIVY trademark a serial number of 97251137. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The PENMENIVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines
penmenivy

General Information


Serial Number97251137
Word MarkPENMENIVY
Filing DateWednesday, February 2, 2022
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7416907
Registration DateTuesday, June 18, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Tuesday, February 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 5, 2022NEW APPLICATION ENTERED
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 15, 2022ASSIGNED TO EXAMINER
Wednesday, November 16, 2022SUSPENSION LETTER WRITTEN
Wednesday, November 16, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, November 16, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, May 30, 2023SUSPENSION INQUIRY WRITTEN
Tuesday, May 30, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, August 30, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 30, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, September 15, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 6, 2024ASSIGNED TO LIE
Wednesday, February 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED